NCT02325518View on ClinicalTrials.gov

Comparison of Intraocular Pressure (IOP)-Lowering Efficacy and Safety of AZORGA® Ophthalmic Suspension and COSOPT® Ophthalmic Solution

PHASE4CompletedINTERVENTIONAL
Enrollment

218

Participants

Timeline

Start Date

December 31, 2014

Primary Completion Date

December 31, 2015

Study Completion Date

December 31, 2015

Conditions
Open-Angle GlaucomaOcular Hypertension
Interventions
DRUG

Brinzolamide 1%/Timolol maleate 0.5% fixed combination ophthalmic suspension

DRUG

Dorzolamide hydrochloride 1%/Timolol maleate 0.5% ophthalmic solution

DRUG

Subject's habitual PGA monotherapy

Trial Locations (1)

107-0052

Contact Alcon Japan Ltd. for Trial Locations, Tokyo

All Listed Sponsors
lead

Alcon, a Novartis Company

INDUSTRY

NCT02325518 - Comparison of Intraocular Pressure (IOP)-Lowering Efficacy and Safety of AZORGA® Ophthalmic Suspension and COSOPT® Ophthalmic Solution | Biotech Hunter | Biotech Hunter